Table: begin end state 1 8 cytoplasmic 9 26 transmembrane 27 31 non-cytoplasmic 32 52 transmembrane 53 61 cytoplasmic 62 80 transmembrane 81 107 non-cytoplasmic 108 136 transmembrane 137 143 cytoplasmic 144 162 transmembrane 163 181 non-cytoplasmic 182 206 transmembrane 207 227 cytoplasmic 228 249 transmembrane 250 268 non-cytoplasmic 269 290 transmembrane 291 301 cytoplasmic 302 323 transmembrane 324 334 non-cytoplasmic 335 358 transmembrane 359 364 cytoplasmic 365 384 transmembrane 385 389 non-cytoplasmic 390 413 transmembrane 414 424 cytoplasmic 425 449 transmembrane 450 450 non-cytoplasmic
Input: >AO356_05055 AO356_05055 permease DsdX MFGMSHETFLLLDAVVTVIGLIVLITKFKFHPFIALTIAAAFLGLTSGMPTGTIIKAFQD GFGGVLGFVGIILALGTMLGKMMAESGGADQIAQTLIRAFGKDKVQWAMMFAAFLVGIPL FFEIGFVLLIPLVFIVARRTGVSIIKIGIPLLAGLSAVHGLVPPHPGPLLAIGIFGADIG KTILYGLIVALPTAIIAGPIFGTFIAKHIPGHPNQELVDQLARETSAAELPSFSITLITV LSPVFLMLLKTFADVALPDGNLFRAWMDMIGHPISALLLALLLSLYTFGYKQGIGSSQML KWLDASLAPTAAIILIIGAGGGFKQMLVTSGVGDVIGHMAVSAQISPILLAWLVAAVIRI ATGSATVATITGAGIVVPVVGMMPGVNRELLVLATGAGSLILSHVNDAGFWLVKQYFNMT VAETFKTWTAMETILSVVGLIFILLLSLVV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server